Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Tadahiro Sasajima is active.

Publication


Featured researches published by Tadahiro Sasajima.


European Journal of Vascular and Endovascular Surgery | 2012

Factors Influencing Wound Healing of Critical Ischaemic Foot after Bypass Surgery: Is the Angiosome Important in Selecting Bypass Target Artery?

Nobuyoshi Azuma; Hisashi Uchida; T. Kokubo; Atsuhiro Koya; Nobuyuki Akasaka; Tadahiro Sasajima

OBJECTIVESnThe aim of the study is to determine factors affecting ischaemic wound healing and role of the angiosome concept in bypass surgery.nnnDESIGNnSingle-centre, retrospective clinical study.nnnMATERIALS AND METHODSnA total of 249 consecutive critical ischaemic limbs with tissue loss in 228 patients who underwent distal bypasses from 2003 to 2009 were reviewed. A total of 81% of patients were diabetic, and 49% of patients had dialysis-dependent renal disease (end-stage renal disease, ESRD). Distal targets of bypasses were the crural artery (57%) and the pedal artery (43%).nnnRESULTSnThe complete healing of ischaemic wounds was achieved in 211 limbs (84.7%). ESRD (odds ratio (OR) 0.127, pxa0<xa00.001), diabetes (OR 0.216, pxa0=xa00.030), Rutherford category 6 (R6) with heel ulcer/gangrene (OR 0.134, pxa0<xa00.001), R6 except heel (OR 0.336, pxa0=xa00.025) and low albuminaemia (OR 0.387, pxa0=xa00.049) were negative predictors of wound healing. Regarding the angiosome, the healing rate in the indirect revascularisation (IR) group was slower than in the direct revascularisation (DR) group, especially in patients with ESRD (pxa0<xa00.001). However, the healing rates of the DR and IR groups were similar after minimising background differences with propensity score methods (pxa0=xa00.185).nnnCONCLUSIONSnIn the field of bypass surgery, the angiosome concept seems unimportant, at least in non-ESRD cases. The location and extent of ischaemic wounds as well as co-morbidities may be more relevant than the angiosome in terms of wound healing.


Circulation | 2006

Transfection of Human Hepatocyte Growth Factor Gene Ameliorates Secondary Lymphedema via Promotion of Lymphangiogenesis

Yukihiro Saito; Hironori Nakagami; Ryuichi Morishita; Yoichi Takami; Yasushi Kikuchi; Hiroki Hayashi; Tomoyuki Nishikawa; Katsuto Tamai; Nobuyoshi Azuma; Tadahiro Sasajima; Yasufumi Kaneda

Background— Lymphedema is a disorder of the lymphatic vascular system characterized by impaired lymphatic return and swelling of the extremities. Treatment for this disabling condition remains limited and largely ineffective. The goal of the present study was to investigate the therapeutic efficacy of hepatocyte growth factor (HGF) in animal models of lymphedema. Methods and Results— Immunofluorescent analysis demonstrated that canine primary lymphatic endothelial cells (cLECs) were positive for lymphatic-specific markers (vascular endothelial growth factor receptor-3, LYVE-1, podoplanin, and Prox1) and the HGF receptor c-Met. Treating cLECs with human recombinant HGF resulted in a dose-dependent increase in cell growth and migration and increased activity of extracellular signal-regulated kinase and Akt. In human LECs, c-Met also was expressed, and treatment with HGF increased cell growth and migration in a dose-dependent manner. Transfection of human HGF plasmid DNA in cLECs also increased the c-fos promoter activity. Furthermore, weekly HGF gene transfer in a rat tail lymphedema model by disruption of lymphatic vessels resulted in a decrease in lymphedema thickness. Although expression of the endothelial cell marker PECAM-1 was increased in both HGF- and vascular endothelial growth factor 165–injected groups, expression of LEC markers (LYVE-1 and Prox1) was increased only in the HGF-injected group. Conclusions— These data demonstrate that expression of HGF via plasmid transfer improves lymphedema via promotion of lymphangiogenesis. Further studies to determine the clinical utility of this approach would be of benefit to patients with lymphedema.


The Annals of Thoracic Surgery | 2008

Vacuum-Assisted Closure for Pediatric Post-Sternotomy Mediastinitis: Are Low Negative Pressures Sufficient?

Takayuki Kadohama; Nobuyuki Akasaka; Akira Nagamine; Keisuke Nakanishi; Keiko Kiyokawa; Kazutomo Goh; Tadahiro Sasajima

We present 3 cases of pediatric post-sternotomy mediastinitis treated by a vacuum-assisted closure (VAC). The patients 2 girls, aged 6 months and 10 months, and a 2-year-old boy. The onset of infection was at 9, 14, and 32 postoperative days. The culture examination detected coagulase-negative Staphylococci strains in 2 cases, and Staphylococcus aureus in 1 case. A VAC was performed at -50 mm Hg for 10, 12, and 7 days. The wounds were closed without vascularized soft tissue. A VAC under a low negative pressure is a useful and safe procedure for the management of pediatric post-sternotomy mediastinitis.


European Journal of Vascular and Endovascular Surgery | 2012

Factors related to postoperative delirium in patients with lower limb ischaemia: a prospective cohort study.

Y. Sasajima; Tadahiro Sasajima; Nobuyoshi Azuma; K. Akazawa; Yukihiro Saito; Masashi Inaba; Hisashi Uchida

OBJECTIVESnTo preoperatively determine candidates at definitive risk of postoperative delirium (POD), we identified relevant factors in patients with arteriosclerosis obliterans who underwent bypass surgery.nnnDESIGNnA prospective cohort study.nnnPATIENTS AND METHODSn299 patients (age ≥ 60 years) who underwent bypasses in 1995-2006 were enrolled. Cognitive impairment was assessed by the Revised Hasegawa Dementia Scale, the Confusion Assessment Method was also used, and severity was graded as Grade I-III (mild to severe) based on the Delirium Rating Scale. All patients were followed for 3 years.nnnRESULTSnPOD occurred in 88 patients (29%), with a median age of 75 (10) years (IQR). Onset was 2 (1) days postoperatively, and a duration of 2 (2) days was observed. POD was hyperactive in 89% and was Grade I, II, and III in 11%, 68%, and 21% respectively. Multiple logistic regression analysis identified the following risk factors for POD: age ≥ 72 years (<0.0001), end-stage renal failure (0.001), multiple occlusive lesions (<0.0001), cognitive impairment (0.003), and critical limb ischaemia (0.034). The 3-year survival rate was similar when comparing POD and non-POD patients (84% vs. 88%, NS).nnnCONCLUSIONSnThis study identified 5 risk factors for POD in patients undergoing bypasses for limb ischaemia. Long-term outcomes were similar when comparing the patients who experienced POD with those who did not.


Journal of Cardiothoracic Surgery | 2011

Mucoepidermoid carcinoma of the lung: a case report

Masahiro Kitada; Yoshinari Matsuda; Kazuhiro Sato; Satoshi Hayashi; Kei Ishibashi; Naoyuki Miyokawa; Tadahiro Sasajima

Mucoepidermoid carcinoma of the lung (MEC) is a tumor of low malignant potential of bronchial gland origin. MEC and adenoid cystic carcinoma are both considered to be salivary gland-type neoplasms. MECs are comparatively rare with an incidence of all lung cancers. We recently encountered a case of this type of lung cancer. A 60-year-old man was found to have an abnormal shadow in the left lower lung field on a regular check-up for lung cancer at his company. Chest radiography and CT revealed a mass shadow measuring 30 mm in diameter in the left lower lung field. Bronchoscopy revealed a protuberant tumor in the S9 bronchus, leading to a diagnosis of low-grade MEC by transbronchial lung biopsy. He underwent left lower lobe resection and mediastinal lymph node dissection using VATS. Tumor cells had a scattering of mucus-producing epithelial components in papillary growth of stratified squamous epithelia with anisokaryosis and minimal pleomorphism, indicating a diagnosis of MEC. Because the postoperative course was good and the tumor was low-grade, no adjuvant treatment was administered. The patient has had no signs of tumor recurrence for 9 months, to date, since resection of the tumor


World Journal of Surgical Oncology | 2010

Adenoid cystic carcinoma of the peripheral lung : a case report

Masahiro Kitada; Keisuke Ozawa; Kazuhiro Sato; Satoshi Hayashi; Yoshihiko Tokusashi; Naoyuki Miyokawa; Tadahiro Sasajima

Adenoid cystic carcinoma of the peripheral lung is a rare entity. We recently encountered a patient with adenoid cystic carcinoma. A 75-year-old woman showed a nodular lesion with 10 mm in diameter in the right upper lung field on chest radiography. The diagnosis was unclear, but lung cancer could not be ruled out. Thoracoscopic biopsy was performed, and intraoperative pathological diagnosis revealed the carcinoma of the lung. We enforced upper lobectomy and mediastinal lymph node dissection to the patient. Histopathological examination revealed adenoid cystic carcinoma with a characteristic cribriform structure. Immunohistochemical examination revealed that the tumor cells were positive for thyroid transcription factor 1 (TTF-1), this tumor was diagnosed primary ACC of the lung.


Annals of Vascular Surgery | 2010

Combined distal venous arterialization and free flap for patients with extensive tissue loss.

Tadahiro Sasajima; Nobuyoshi Azuma; Hisashi Uchida; Hidenori Asada; Masashi Inaba; Nobuyuki Akasaka

BACKGROUNDnWe evaluated the mid-term outcome of distal venous arterialization (DVA) and the role of a combined free flap as a bridgehead for blood supply.nnnMETHODSnIn the past 5 years, nine patients with extensive tissue loss and lacking graftable distal arteries underwent DVA. These consisted of four primary DVAs, three combined DVA and free flap procedures, and two adjuvant DVAs for hemodynamically failed distal bypasses. After nine primary DVAs, three redo DVAs were performed for early failure. Etiologies were four Buerger disease and five arteriosclerosis obliterans, including three dialysis patients.nnnRESULTSnAmong the nine DVA cases, there were five primary failures: two underwent amputation, two had successful redo DVA, and the remaining one did not require redo DVA. Primary patency, secondary patency, and limb salvage rates were 44.4%, 55.6%, and 77.8%, respectively. The postoperative period was 1-36 months (median 12). Angiography demonstrated DVA was effective in the early period, and development of collaterals or a capillary network from the free flap replaced the DVA function in the intermediate period.nnnCONCLUSIONnDVA can be effective as a procedure for limb salvage in patients without graftable distal arteries, and a combined free flap is effective and functions as a bridgehead for blood supply to the ischemic zone.


World Journal of Surgical Oncology | 2011

Ectopic thymoma presenting as a giant intrathoracic tumor: A case report

Masahiro Kitada; Kazuhiro Sato; Yoshinari Matsuda; Satoshi Hayashi; Yoshihiko Tokusashi; Naoyuki Miyokawa; Tadahiro Sasajima

Ectopic thymoma rarely presents as an intrathoracic tumor. We report a case of ectopic thymoma presenting as a giant right intrathoracic tumor that was treated with resection. The patient was a 50-year-old Japanese woman who presented with the chief complaint of chest pain. Detailed examination revealed a solid tumor measuring 15 × 10 × 8 cm in diameter, with a clear border. The Imaging findings suggested a solitary fibrous tumor, and surgery was performed. At surgery, the tumor was found to beadherent to the diaphragm, mediastinal pleura, and lower lobe of the lung, although it could be dissected with relative ease and was removed. Pathological diagnosis indicated a type B1 tumor with no capsular invasion according to the World Health Organization classification, and a diagnosis of Masaoka stage I thymoma was made. No continuity with the normal thymus tissue was seen, and the thymoma was considered to be derived from ectopic thymic tissue in the pleura.


World Journal of Surgical Oncology | 2011

Alpha-fetoprotein-producing primary lung carcinoma: A case report

Masahiro Kitada; Keisuke Ozawa; Kazuhiro Sato; Yoshinari Matsuda; Satoshi Hayashi; Yoshihiko Tokusashi; Naoyuki Miyokawa; Tadahiro Sasajima

Alpha-fetoprotein (AFP)-producing lung adenocarcinoma is a rare type of lung cancer, with its characteristics not yet fully clarified. We recently encountered a case of this type of lung cancer. The patient was a 69-year-old man who consulted an internist with the chief complaint of epigastric pain. Chest X-ray and CT revealed a lobulated mass measuring 70 mm in diameter in the right lower lung field and a metastasis in the right hilar lymph nodes. Of the tumor markers, the serum AFP was elevated (4620 ng/ml), and the serum carcinoembryonic antigen and carbohydrate antigen 19-9 were also slightly elevated. Transbronchial lung biopsy revealed the diagnosis of lung cancer. Under thoracoscopic assistance, right lower lobectomy + mediastinal lymph node dissection was carried out. Immunostaining showed the tumor cells to be AFP-positive. The tumor was thus diagnosed as an AFP-producing lung adenocarcinoma. The patient followed an uneventful clinical course after the surgery, with serum AFP decreasing to the normal range by about 2 weeks after the surgery. As of this writing, no sign of tumor recurrence has been noted. This case is presented here with a review of the literature.


Asian Cardiovascular and Thoracic Annals | 2012

Ruptured aneurysm of coronary artery-to-pulmonary artery fistula

Kei Kazuno; Nobuyuki Akasaka; Keiko Kiyokawa; Tadahiro Sasajima

A 69-year-old lady was discovered unconscious. Computed tomography showed pericardial effusion and a coronary artery aneurysm of 25u2009mm in diameter in front of the main pulmonary artery. Emergency surgery revealed a coronary-pulmonary artery fistula and coronary aneurysm surrounded by a large hematoma. The inflow and outflow of the fistula were closed, and no cardioplegic leakage was noted. Postoperative angiography showed residual fistulas that were successfully closed by transcatheter embolization.

Collaboration


Dive into the Tadahiro Sasajima's collaboration.

Top Co-Authors

Avatar

Nobuyoshi Azuma

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Kazuhiro Sato

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Masahiro Kitada

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Satoshi Hayashi

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Hisashi Uchida

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Masashi Inaba

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Nobuyuki Akasaka

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Naoyuki Miyokawa

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Kazutomo Goh

Asahikawa Medical University

View shared research outputs
Top Co-Authors

Avatar

Keisuke Ozawa

Asahikawa Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge